Literature DB >> 11928525

Pathological determinants of the transition to clinical dementia in Alzheimer's disease.

Donald R Royall1, Raymond Palmer, Amy R Mulroy, Marsha J Polk, Gustavo C Román, Jean-Phillippe David, André Delacourte.   

Abstract

The authors developed multivariate models to examine the association between Clinical Dementia Rating (CDR) scale scores and the spatial distribution of paired helical filament tau (PHF-tau) pathology. Severity of tauopathy was examined in 14 cortical regions of interest (ROIs). Classification trees were used to test the independent hierarchical contributions of each ROI to dementia. Multiple-regression and cluster analyses were performed to determine the relative contributions of select ROIs to dementia. Dementia (CDR > or = 1) was modeled as a dichotomous variable. Autopsy material was obtained from 124 demented and nondemented elderly patients. All ROIs except the hippocampus made significant contributions to dementia. However, they were not independent. In multivariate models, only a single step (Step 7 in a hierarchical progression), which contained four ROIs, contributed significantly to dementia. A classification tree resulted in a single decision split, suggesting that only Step 7 ROIs need be considered. A total of 89.4% of the cases were correctly classified (p < .0001). Twelve discrepant cases all had superimposed vasculopathy that might also have affected the function of Step 7 ROIs. The transition to clinical dementia was associated with the presence of tauopathy in A9/10, A22, A23, and A39. Animal studies suggest that these represent a single distributed cortical network focusing on prefrontal regions that provide "executive control" over complex goal-directed behaviors. A22, A23, and A39 provide major afferents to other frontal systems and have previously been implicated in very early clinical Alzheimer's disease.

Entities:  

Mesh:

Year:  2002        PMID: 11928525     DOI: 10.1080/03610730252800166

Source DB:  PubMed          Journal:  Exp Aging Res        ISSN: 0361-073X            Impact factor:   1.645


  14 in total

1.  Detection and quantification of tau aggregation using a membrane filter assay.

Authors:  Edward Chang; Jeff Kuret
Journal:  Anal Biochem       Date:  2007-09-19       Impact factor: 3.365

Review 2.  Modulation and detection of tau aggregation with small-molecule ligands.

Authors:  Edward Chang; Nicolette S Honson; Bhaswati Bandyopadhyay; Kristen E Funk; Jordan R Jensen; Sohee Kim; Swati Naphade; Jeff Kuret
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

3.  Modeling regional vulnerability to Alzheimer pathology.

Authors:  Donald R Royall; Raymond F Palmer; Helen Petrovitch; G Webster Ross; Kamal Masaki; Lon R White
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

4.  Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Alzheimers Dement       Date:  2012-11-13       Impact factor: 21.566

5.  The default mode network and related right hemisphere structures may be the key substrates of dementia.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type.

Authors:  Tiffany W Chow; Malcolm A Binns; Jeffrey L Cummings; Isabel Lam; Sandra E Black; Bruce L Miller; Morris Freedman; Donald T Stuss; Robert van Reekum
Journal:  Arch Neurol       Date:  2009-07

7.  Differentiating Alzheimer disease-associated aggregates with small molecules.

Authors:  Nicolette S Honson; Ronald L Johnson; Wenwei Huang; James Inglese; Christopher P Austin; Jeff Kuret
Journal:  Neurobiol Dis       Date:  2007-07-28       Impact factor: 5.996

Review 8.  Tau aggregation and toxicity in tauopathic neurodegenerative diseases.

Authors:  Nicolette S Honson; Jeff Kuret
Journal:  J Alzheimers Dis       Date:  2008-08       Impact factor: 4.472

Review 9.  Cholinergic dysfunction in vascular dementia.

Authors:  Gustavo C Román
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 8.081

10.  Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.

Authors:  Stefani N Thomas; Kristen E Funk; Yunhu Wan; Zhongping Liao; Peter Davies; Jeff Kuret; Austin J Yang
Journal:  Acta Neuropathol       Date:  2011-10-28       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.